Setx Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
SETX Protein (Senataxin) is a large DNA/RNA helicase that plays critical roles in transcription regulation, RNA processing, and DNA repair. Mutations in this protein cause juvenile-onset ALS (ALS4) and ataxia-ocular apraxia syndrome (AOA2). [1]
| Attribute | Value | [2]
|-----------|-------| [3]
| Protein Name | SETX / Senataxin | [4]
| Gene | SETX | [5]
| UniProt ID | Q7Z594 | [6]
| Molecular Weight | ~303 kDa | [7]
| Subcellular Localization | Nucleus |
| Protein Family | Superfamily 1 DNA helicases |
SETX is a very large protein (~2678 amino acids) containing:
SETX functions as:
SETX plays a crucial role in resolving R-loops, which are three-stranded nucleic acid structures that form during transcription when RNA hybridizes with template DNA. These structures, if not properly resolved, can:
The helicase activity of SETX (ATP-dependent 5' to 3' direction) is essential for displacing the RNA strand and allowing proper DNA repair machinery access. Studies show that ALS4-associated mutations reduce helicase activity by 40-60%, leading to R-loop accumulation in neuronal cells.
SETX cooperates with the Sen1/SEN1-like helicase in yeast to facilitate transcription termination of RNA polymerase II. In mammals, SETX is recruited to sites of transcription elongation and helps:
SETX participates in transcription-coupled nucleotide excision repair (TC-NER), a pathway that removes bulky DNA lesions from the transcribed strand of active genes. The protein interacts with:
SETX is widely expressed in human tissues with highest levels in:
In the brain, SETX expression is particularly high in:
This expression pattern correlates with the selective vulnerability observed in ALS4 and AOA2.
Recent research focuses on:
The study of Setx Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Morea P, et al. (2020) Clinical and functional characterization of SETX mutations. Neurology. 2020. ↩︎
Suraweera A, et al. (2009) Senataxin, defective in ataxia-ocular apraxia 2, is involved in the defense against oxidative stress. J Cell Biol. 2009. ↩︎
Labbé C, et al. (2017) SETX mutations in a cohort of patients with ALS and ataxia. Neurology. 2017. ↩︎
Bennett CL, et al. (2008) Senataxin, a novel helicase at the interface of transcription and DNA repair. Neurology. 2008. ↩︎
Groh M, et al. (2017) R-loops and diseases: How the DNA:RNA helix pays the price. Med Sci (Paris). 2017. ↩︎
Belhadj S, et al. (2020) R-loop resolution: A new step in DNA repair. Nat Rev Mol Cell Biol. 2020. ↩︎
Cantor SB, et al. (2019) SETX and the DNA damage response. DNA Repair. 2019. ↩︎